These “double-hit” or “triple-hit” lymphomas [19] are included in the updated WHO classification in the category of high-grade B‐cell lymphoma (HGBL), with rearrangements of MYC and BCL2 and/or BCL6. This evidence concerns the gene BCL6 and B-cell non-Hodgkin lymphoma.